Grapefruit News and Research

RSS
Study confirms QT-prolonging effects of grapefruit juice

Study confirms QT-prolonging effects of grapefruit juice

Coffee, sugary drinks, or alcohol? It's in your genes.

Coffee, sugary drinks, or alcohol? It's in your genes.

Using computer model to visualize brain's internal valuation system

Using computer model to visualize brain's internal valuation system

Community hospitals link arms with prestigious facilities to raise their profiles

Community hospitals link arms with prestigious facilities to raise their profiles

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Avoidable sepsis infections send thousands of seniors to gruesome deaths

Avoidable sepsis infections send thousands of seniors to gruesome deaths

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment